Thrivent Financial for Lutherans Sells 53,047 Shares of SPDR S&P Biotech ETF $XBI

Thrivent Financial for Lutherans cut its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 39.0% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 82,897 shares of the exchange traded fund’s stock after selling 53,047 shares during the quarter. Thrivent Financial for Lutherans owned approximately 0.14% of SPDR S&P Biotech ETF worth $8,307,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. 5th Street Advisors LLC grew its holdings in SPDR S&P Biotech ETF by 3.4% in the third quarter. 5th Street Advisors LLC now owns 18,687 shares of the exchange traded fund’s stock worth $1,872,000 after purchasing an additional 615 shares during the period. Cornerstone Wealth Management LLC grew its stake in shares of SPDR S&P Biotech ETF by 9.2% in the 3rd quarter. Cornerstone Wealth Management LLC now owns 7,604 shares of the exchange traded fund’s stock worth $762,000 after buying an additional 639 shares during the last quarter. AE Wealth Management LLC increased its position in SPDR S&P Biotech ETF by 10.8% during the 3rd quarter. AE Wealth Management LLC now owns 22,835 shares of the exchange traded fund’s stock valued at $2,288,000 after buying an additional 2,235 shares in the last quarter. Absolute Capital Management LLC purchased a new position in SPDR S&P Biotech ETF during the third quarter valued at $1,232,000. Finally, Mirae Asset Global Investments Co. Ltd. bought a new stake in SPDR S&P Biotech ETF in the third quarter worth $1,287,000.

SPDR S&P Biotech ETF Trading Down 3.6%

NYSEARCA XBI opened at $120.72 on Friday. SPDR S&P Biotech ETF has a 12 month low of $66.66 and a 12 month high of $132.09. The stock’s fifty day moving average price is $124.06 and its 200-day moving average price is $108.17. The stock has a market cap of $8.07 billion, a P/E ratio of 11.47 and a beta of 0.93.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.